Animal Health Market Report 2026

Animal Health Market Overview

• Animal Health market size has reached to $59.77 billion in 2025 • Expected to grow to $89.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Rising Zoonotic Disease Prevalence Drives Growth In The Animal Health Market • Market Trend: Electronic Prescription And Delivery Platforms Expanding Animal Health Access • North America was the largest region in 2025.

What Is Covered Under Animal Health Market?

Animal health is defined as a term that covers animal diseases and the relationship between animal welfare, environment protection, human health, and food safety. Animal health is used for sustaining the healthy development of animals. The main products in animal health market are vaccines, pharmaceuticals, medicinal feed additives, diagnostics, equipment and disposables and others. Commercial animals or livestock can be defined as living animals that are grown or raised for commercial purposes. Animal health is used for improving the productivity of commercial animals, extracting income, and keeping all animals disease free. These are used by commercial and companion animal types through oral, parenteral and topical route of administration. These are used by various end users such as veterinary hospitals and clinics, animal care and rehabilitation centers and diagnostic centers.

What Is The Animal Health Market Growth Forecast?

The animal health market size is expected to see strong growth in the next few years. It will grow to $89.45 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in genomic-based vaccines, growth of AI-enabled diagnostics, increasing adoption of feed additives, rising focus on animal welfare, expansion of point-of-care testing devices. Major trends in the forecast period include increasing focus on preventive animal healthcare, growth in companion animal wellness programs, expansion of laboratory and point-of-care diagnostics, rising adoption of medicinal feed additives, development of herbal and nutraceutical supplements.

Global Animal Health Market Segmentation

1) By Product: Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics , Equipment And Disposables, Other Products 2) By Animal Type: Commercial, Companion 3) By Route Of Administration: Oral, Parenteral, Topical 4) By End-User: Veterinary Hospitals And Clinics, Animal Care And Rehabilitation Centers, Diagnostic Centers Subsegments: 1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines 2) By Pharmaceuticals: Anti-Infective Agents, Anti-Inflammatory Drugs, Parasiticides, Pain Management Medications 3) By Medicinal Feed Additives: Probiotics, Prebiotics, Antimicrobials, Enzymes 4) By Diagnostics: Laboratory Diagnostic Tests, Point-Of-Care Testing Devices, Imaging Equipment 5) By Equipment And Disposables: Surgical Instruments, Monitoring Devices, Disposable Syringes And Needles 6) By Other Products: Nutraceuticals, Supplements, Herbal Medicines

What Is The Driver Of The Animal Health Market?

The increasing prevalence of zoonotic diseases will support the growth of the animal health market going forward. Zoonotic diseases can be defined as infectious diseases that can be transmitted between different animal species to humans or from humans to animals. Monitoring and safeguarding animal health using different methods helps in controlling zoonosis and can help in protecting public health. For instance, in June 2023, according to the National Library of Medicine, a US-based National Library of Medicine, operated by the United States federal government, zoonotic diseases are responsible for 2.5 billion human cases globally and approximately 2.7 million deaths annually. Therefore, the increasing prevalence of zoonotic diseases will propel the animal health industry.

Key Players In The Global Animal Health Market

Major companies operating in the animal health market are Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim International GmbH, Heska Corporation, Vetoquinol SA, Virbac, Bayer AG, Novartis AG, Biogenesis Bago, Intervet International BV, IDEXX Laboratories Inc., Hester Biosciences Ltd., Intas Pharmaceutucals Ltd., Dechra Pharmaceuticals, Kindred Biosciences, Phibro Animal Health Corporation, Neogen Corporation, Norbrook Laboratories, Huvepharma EOOD, Abaxis Inc., ECO Animal Health Group, Hipra, Zoetis Inc., Kemin Industries, Troy Laboratories, Parnell Pharmaceuticals, Ceva Sante Animale, Bimeda Inc., Animalcare Group, PetIQ, AdvaVet Inc.

Global Animal Health Market Trends and Insights

Major companies operating in the animal health market are focusing on technological advancements, such as electronic prescription and delivery platforms, to gain a competitive advantage. Electronic prescription and delivery platforms are integrated digital systems that allow veterinarians to create, transmit, and manage prescriptions electronically and link them to fulfillment services that deliver prescribed medications directly to animal owners within a prescription delivery service framework, improving access, convenience, and adherence to treatment regimens. For instance, in January 2025, PetsApp Ltd, a UK-based digital pet health platform company, launched an expanded Prescriptions Home Delivery service in partnership with Covetrus Inc is a US-based company that provides animal health technology and National Veterinary Services Limited is a UK-based explicitly committed to and involved in providing animal health services and products, that offers next-day delivery of prescribed animal medications, automated refill management, and bespoke delivery options tailored to clinic and owner needs. This innovation enhances timely access to essential therapies and supports clinic workflows but may require investment in digital integration and training for some practices.

What Are Latest Mergers And Acquisitions In The Animal Health Market?

In April 2024, Phibro Animal Health Corporation, a US-based provider of animal health and nutrition products, including medicated feed additives, vaccines, and specialty nutritional solutions, acquired Zoetis Inc.’s medicated feed additive (MFA) product portfolio, certain water-soluble products, and related assets for $350 million. With this acquisition, Phibro expanded its species and product offerings across cattle, swine, and poultry, strengthening its integrated solutions in animal health, disease prevention, and nutrition while enhancing its global manufacturing footprint and revenue base. Zoetis Inc. is a US-based animal health company that develops, manufactures, and markets vaccines, parasiticides, therapeutics, and other products for livestock and companion animals.

Regional Outlook

North America was the largest region in the animal health market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Animal Health Market?

The animal health market consists of sales of biologics and flea and tick medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.